Probiotic therapy alleviates SIBO but has no effect on liver disease

Researchers study use of probiotic therapy in patients with liver disease and SIBO

Oct 1, 2014 · 1 minute read

This research focused on the benefits of using probiotic therapy for patients with chronic liver disease, small intestinal bacterial overgrowth (SIBO) and intestinal permeability problems. The study enrolled 53 patients who consumed for 4 weeks a cocktail of 6 bacterial species. The result was that SIBO was resolved in many of the patients but intestinal permeability was not. This led the researchers to conclude that in liver disease patients’ probiotics are effective treatment for SIBO.

Ref: Eur J Gastroenterol Hepatol 2014 Sept 19

http://www.ncbi.nlm.nih.gov/pubmed/25244414

Other blogs you might like

IBS Patients found to have lactose intolerance and fructose malabsorption

Research has found that lactose and fructose intolerances are a frequent but underestimated condition in patients with IBS symptoms.

Read post

Low FODMAP diet improves symptoms in IBS patients

This research studied 90 patients with confirmed irritable bowel syndrome (IBS). The goal was to determine if a low FODMAP...

Read post

Is Leaky Gut Syndrome Real?

New research is showing that the debate about leaky gut syndrome is turning to a general agreement that this is a real medical condition.

Read post

Back to all blog posts

Metabolic Solutions offers a broad spectrum of assays utilizing stable isotopes such as carbon-13 (¹³C), nitrogen-15 (¹⁵N), deuterium (²H), and oxygen-18 (¹⁸O).

We have developed and validated non-invasive breath tests that assess sugar intolerances and gastrointestinal health.

Probiotic therapy alleviates SIBO but has no effect on liver disease

Other blogs you might like

IBS Patients found to have lactose intolerance and fructose malabsorption

Low FODMAP diet improves symptoms in IBS patients

Is Leaky Gut Syndrome Real?

Contact us

Research Services

GI Breath Tests

About Metabolic Solutions

Metabolic Solutions offers a broad spectrum of assays utilizing stable isotopes such as carbon-13 (13C), nitrogen-15 (15N), deuterium (2H), and oxygen-18 (18O).

We have developed and validated non-invasive breath tests that assess sugar intolerances and gastrointestinal health.

Probiotic therapy alleviates SIBO but has no effect on liver disease

Other blogs you might like

IBS Patients found to have lactose intolerance and fructose malabsorption

Low FODMAP diet improves symptoms in IBS patients

Is Leaky Gut Syndrome Real?

Get notified on new research technologies

Contact us

Research Services

GI Breath Tests

About Metabolic Solutions

Metabolic Solutions offers a broad spectrum of assays utilizing stable isotopes such as carbon-13 (¹³C), nitrogen-15 (¹⁵N), deuterium (²H), and oxygen-18 (¹⁸O).